Explore the details of the In Re Selenious Acid Litigation case under case number 2:24-cv-07791 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:24-cv-07791
Filing Date
Jul 16, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
CIPLA LIMITED -
HIKMA PHARMACEUTICALS USA INC. -
EUGIA PHARMA SPECIALTIES LTD. -
IN RE SELENIOUS ACID LITIGATION -
ASPIRO PHARMA LTD. -
ACCORD HEALTHCARE INC. -
DR. REDDY'S LABORATORIES, LTD. -
ZYDUS PHARMACEUTICALS (USA) INC. -
SOMERSET PHARMA, LLC -
RK PHARMA, INC. -
AMERICAN REGENT, INC. -
SUN PHARMACEUTICAL INDUSTRIES LIMITED -
GLAND PHARMA LIMITED -
XIROMED PHARMA ESPANA, S.L. -
XIROMED, LLC -
ODIN PHARMACEUTICALS, LLC -
LONG GROVE PHARMACEUTICALS, LLC -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 8, 2025REDACTED OPINION Signed by Judge Brian R. Martinotti on 5/27/2025. (arm)PACER Document